Why Is SELLAS LIFE SCIENCES (SLS) Stock Down Today?

By the Top Tier Newswire AI Desk · August 11, 2026 at 4:16 AM ET · reviewed against 1 wire stories

SELLAS LIFE SCIENCES (SLS) is down -8.08% in the latest session. Our newswire has captured 1 story on SLS across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 53/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

SLS stock fell 8.08% to $11.04 in a session marked by renewed investor skepticism. The decline came after the company faced an arbitration ruling that dismissed its claims against 3D Medicines and ordered it to pay approximately $1 million in legal fees. The move also occurred ahead of an expected earnings update that analysts anticipate will show no quarterly revenue and a GAAP loss of $0.04 per share.

What Happened

SELLAS Life Sciences shares dropped sharply following the arbitration decision, which ruled against the company in its dispute with 3D Medicines. The ruling not only dismissed SELLAS’s claims but also required it to cover legal costs, adding to the company’s financial pressures. The stock had previously risen in premarket trading after hitting a three-week low, but the broader market reaction remained bearish. Retail traders are watching for an upcoming earnings report that is expected to show a narrowing GAAP loss but no revenue, which may further test investor confidence.

What The Data Shows

Over the past eight sessions, SLS shares had gained 15.7% from $10.29 to $11.91. The stock currently trades within its 52-week range of $1.39 to $15.88 and has a market capitalization of $2.3 billion. The company remains unprofitable with a trailing twelve-month earnings per share of -0.23 and a beta of 2.49, indicating higher volatility than the broader market.

What To Watch

Investors will be closely watching SELLAS Life Sciences for its upcoming earnings update, which is expected to provide clarity on the company’s financial performance and future direction.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

SLS by the numbers

Last: $11.04Session: -8.08%7 sessions: +15.74%Coverage: 1 stories / 1 sourcesAI sentiment: 53/100 (mixed)Mkt cap: $2.3B52w: $1.39 to $15.88

SLS · today's session (5-min) · +1.14% vs prior close · updated 8:57 AM ET

AI sentiment, last 36h · averaged over 1 story · 53/100 neutral

The headlines behind the move

Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline

4h agoStocktwits NewsNEUTRAL 53Earnings

SLS Stock Rebounds Premarket After Worst Day In 3 Weeks — Retail Awaits ‘Very Special’ Earnings Update

Wall Street expects no quarterly revenue and a GAAP loss of $0.04 per share, narrowing from $0.05 previously.

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on SLS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier SLS move explainers: 2026-08-11 · 2026-08-04 · 2026-08-03 · 2026-07-27 · 2026-07-24 · 2026-07-22 · 2026-07-20 · 2026-07-17 · 2026-07-13